0 likes | 12 Views
The global cerebral infarction market is anticipated to attain a CAGR ~8% over the forecast period, i.e., 2023 u2013 2035. The market is segmented on the basis of drug class into tissue plasminogen activators (tPA), anticoagulants, and others, out of which, the tissue plasminogen activators (tPA) segment is projected to hold the largest share over the forecast period as this protein is being used to breakdown the blood clots in the patients.
E N D